Screening before Age 50 Reduces the Incidence of Colorectal Cancer in Women
Massachusetts General Hospital
Research could have major health care implications on both individual and population-wide scales
Colonoscopy
NRG Oncology Launches FORTE, a Colorectal Cancer Prevention Clinical Trial
NRG Oncology
FORTE is a large, randomized trial of surveillance colonoscopy for participants with one or two small benign polyps
Evidence Supports 10-Year Screening Interval After a Colonoscopy with Normal Findings
Kaiser Permanente
Prior to this study, there was little evidence supporting the 10-year recommended screening interval